Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ABOS
ALXO
Add up to 3 more stocks
ABOS
Acumen Pharmaceuticals, Inc.
-2.35%
$2.08-0.05Delayed quote: Oct 6, 2026, 11:00 AM EDT
Market Cap
$150.23M
52W Range
$1.50 - $3.60
ALXO
ALX Oncology Holdings Inc.
-5.79%
$1.14-0.07Delayed quote: Oct 6, 2026, 11:00 AM EDT
Market Cap
$153.40M
52W Range
$1.05 - $2.66
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.62 | 1.13 |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% |
| ROE | -183.4% | -59.4% |
| ROA | -90.5% | -50.3% |
| ROIC | -118.7% | -56.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.47 | 9.71 |
| Quick Ratio | 2.47 | 9.71 |
| Debt/Equity | 0.55 | 0.07 |
| Interest Coverage | -29.32 | -64.93 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.